These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 7017368)
41. Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report. Heyn R; Khan F; Ensign LG; Donaldson SS; Ruymann F; Smith MA; Vietti T; Maurer HM Med Pediatr Oncol; 1994; 23(2):99-106. PubMed ID: 8202048 [TBL] [Abstract][Full Text] [Related]
42. A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia. Hijiya N; Gaynon P; Barry E; Silverman L; Thomson B; Chu R; Cooper T; Kadota R; Rytting M; Steinherz P; Shen V; Jeha S; Abichandani R; Carroll WL Leukemia; 2009 Dec; 23(12):2259-64. PubMed ID: 19741725 [TBL] [Abstract][Full Text] [Related]
43. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission. Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272 [TBL] [Abstract][Full Text] [Related]
44. Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia. Whitlock JA; Greer JP; Lukens JN Cancer; 1991 Aug; 68(3):600-4. PubMed ID: 1648435 [TBL] [Abstract][Full Text] [Related]
45. High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung. Cunningham D; Banham SW; Hutcheon AH; Dorward A; Ahmedzai S; Tansey P; Soukop M; Stevenson RD; Stack BR; Kaye SB Cancer Chemother Pharmacol; 1985; 15(3):303-6. PubMed ID: 2996799 [TBL] [Abstract][Full Text] [Related]
46. High-dose cyclophosphamide, BCNU, and etoposide followed by autologous bone marrow rescue as treatment for adult acute leukemia in relapse. Vellekoop L; Jagannath S; Spitzer G; Zander AR; Horwitz LJ; Keating M; McCredie KB; Dicke KA Am J Clin Oncol; 1986 Aug; 9(4):307-10. PubMed ID: 3529919 [TBL] [Abstract][Full Text] [Related]
47. Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213. Jackson DV; Wells HB; White DR; Muss HB; Richards F; Cooper MR; Stuart JJ; Pope EK; Spurr CL Am J Clin Oncol; 1983 Jun; 6(3):327-30. PubMed ID: 6303106 [TBL] [Abstract][Full Text] [Related]
48. Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma. Hänel M; Kröger N; Sonnenberg S; Bornhäuser M; Krüger W; Kroschinsky F; Hänel A; Metzner B; Birkmann J; Schmid B; Hoffknecht MM; Fiedler F; Ehninger G; Zander AR Ann Hematol; 2002 Feb; 81(2):96-102. PubMed ID: 11907790 [TBL] [Abstract][Full Text] [Related]
49. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide. Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007 [TBL] [Abstract][Full Text] [Related]
50. [The value of etoposide (VP-16) in the therapy of refractory ovarian cancer]. Marth C; Pointner E; Zeimet AG; Abfalter E; Koza A; Windbichler G; Hetzel H; Dapunt O Geburtshilfe Frauenheilkd; 1993 May; 53(5):303-7. PubMed ID: 8514100 [TBL] [Abstract][Full Text] [Related]
51. Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients. Miano M; Pistorio A; Putti MC; Dufour C; Messina C; Barisone E; Ziino O; Parasole R; Luciani M; Lo Nigro L; De Rossi G; Varotto S; Bertorello N; Petruzziello F; Calvillo M; Micalizzi C Leuk Lymphoma; 2012 Sep; 53(9):1693-8. PubMed ID: 22303898 [TBL] [Abstract][Full Text] [Related]
52. [Effects of oral etoposide in small cell carcinoma of the lung]. Miyamoto H; Ito M; Araya Y; Takaoka K; Isobe H; Dosaka H; Kawakami Y; Shimizu T; Onodera S Gan To Kagaku Ryoho; 1984 Jun; 11(6):1244-7. PubMed ID: 6329103 [TBL] [Abstract][Full Text] [Related]
53. VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer. Evans WK; Feld R; Osoba D; Shepherd FA; Dill J; Deboer G Cancer; 1984 Apr; 53(7):1461-6. PubMed ID: 6321006 [TBL] [Abstract][Full Text] [Related]
54. Epipodophyllotoxin (VP-16-213) in mycosis fungoides: A report from the Scandinavian mycosis fungoides study group. Molin L; Thomsen K; Volden G; Bergqvist-Karlsson A; Hallberg O; Hellbe L Acta Derm Venereol; 1979; 59(1):84-7. PubMed ID: 84480 [TBL] [Abstract][Full Text] [Related]
55. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma. Newlands ES Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442 [TBL] [Abstract][Full Text] [Related]
56. CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemia. Kornblau SM; Kantarjian H; O'Brien S; Andreeff M; Koller CA; Beran M; Keating M; Estey E Leuk Lymphoma; 1998 Jan; 28(3-4):371-5. PubMed ID: 9517508 [TBL] [Abstract][Full Text] [Related]
57. [A phase II clinical trial of oral VP 16-213 in advanced non-Hodgkin's lymphoma]. Nakada H; Ogawa M; Ingaki J; Horikoshi N; Inoue K; Usui N; Adachi K; Tada A; Yamazaki H; Mukaiyama T Gan To Kagaku Ryoho; 1984 Aug; 11(8):1644-8. PubMed ID: 6476837 [TBL] [Abstract][Full Text] [Related]
58. Cyclophosphamide-asparaginase- vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia. Komp DM; George SL; Falletta J; Land VJ; Starling KA; Humphrey GB; Lowman J Cancer; 1976 Mar; 37(3):1243-7. PubMed ID: 1063049 [TBL] [Abstract][Full Text] [Related]
59. VP-16: phase specific cytocidal activity and preliminary trials in acute monocytic leukemias. Izumi Y; Okazaki T; Mochizuki T; Ishikura H; Tashima M; Sasada M; Sawada H; Uchino H Nihon Gan Chiryo Gakkai Shi; 1986 Apr; 21(3):591-600. PubMed ID: 3525706 [No Abstract] [Full Text] [Related]
60. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies. Giralt SA; LeMaistre CF; Vriesendorp HM; Andersson BS; Dimopoulos M; Gajewski J; Van Besien K; Mehra R; Przepiorka D; Khouri I J Clin Oncol; 1994 Sep; 12(9):1923-30. PubMed ID: 8083714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]